Indivior Pharmaceuticals, Inc. - 8-K Filing
Indivior reports record Q3 2026 results with $356M revenue and announces merger with Supernus expected to close November 2, 2026 (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $INDV
Read the full article at SEC EDGAR
Part of the story Cloudflare Shares Surge Following Strong Q3 Results and Raised Full-Year Guidance (85 articles)